Latest European Patent Organisation Stories
BRUSSELS and MUNICH, February 26, 2015 /PRNewswire/ -- - Patent filings at the European Patent Office (EPO) reach all-time high in 2014
MORIN-HEIGHTS, QC, Jan. 30, 2015 /CNW Telbec/ - Capital Pro-Égaux Inc.
MUNICH, January 22, 2015 /PRNewswire/ -- - Europe's most prestigious innovation prize celebrates its tenth year - The European Patent Office to present
MONCHENGLADBACH, Germany and NINGBO, China, Nov. 27, 2014 /PRNewswire/ -- Ningbo Signatronic Technologies, Ltd., and TaLa UG & Co.
MELBOURNE, Australia and BARCELONA, October 31, 2014 /PRNewswire/ -- Multigate Medical Devices Pty Ltd (Multigate) was found to infringe two Australian patents of B.
TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing
JENA, Germany, July 23, 2014 /PRNewswire/ -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced
Copan’s attack was blown away by the District Court Düsseldorf. Guilford, ME (PRWEB) July 17, 2014 At an oral hearing on June 24, 2014 (case no.
HAMM, Germany, May 9, 2014 /PRNewswire/ -- In December 2011, Align Technology filed a patent infringement lawsuit against Ortho Caps GmbH (maker of orthocaps(R) aligners)
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- The governor of a province or people.